Interleukin-8 (IL-8), is a potent activator of polymorphonuclear leukocyte (PMN) functions including chemotaxis, superoxide anion production, and enzyme release and it is also chemotactic for lymphocytes. Additionally, it has recently been shown that IL-8 stimulates the formation of 5-1ipoxygenase (LO) products of arachidonic acid (AA) by human PMNs. The purpose of the present study was to determine whether IL-8 also might affect the formation of 15-LO products from AA. Purified PMNs in phosphate buffered saline were preincubated with and without exogenous AA (10-5_ 10-4 M) for 10 min. Then IL-8 was added in biologically relevant concentrations ranging from 0.1 to 100 ng/ml and incubation was carried out for 5 min at 37 ~ Lipids were then extracted from supernatants, and eicosanoids were determined by quantitative RP-HPLC. Compared with unstimulated cells, IL-8 resulted in a dose dependent increase in both LTB 4 and 15-HETE (up to 125% and 40% at 100 ng/ml, respectively). This increase in eicosanoid formation required the presence of exogenous AA. These results indicate that IL-8 is both a potent stimulator of 5-LO activity and of 15-LO activity. LTB 4 can induce both inflammation and contribute to hyperproliferation in the skin. 15-HETE in contrast has the ability to inhibit the effects induced by LTB 4. Because IL-8 is able to stimulate both LTB 4 and 15-HETE formation, the effect of IL-8 as a putative regulator of inflammatory processes may be dependent on the relative stimulation of 5-LO and 15-LO.
Introduction
A variety of proinflammatory mediators are released in cutaneous inflammation. These mediators include peptide-like substances, interleukin-I [1, 2] , complement C5a [3, 4] and bacterial F-Met peptides [5] and lipid-like mediators derived from arachidonic acid, leukotriene B 4 (LTB4) and 12- Author for correspondence/Present address: Karsten Fogh, University of Michigan Medical Center, Department of Dermatology, Kresge I, Box 0528, Ann Arbor, Michigan 48109-0528, USA. * Part of this work has been presented at the Annual Meeting of the European Society for Dermatological Research (E.S.D.R.), Turin, Italy, June, 1990. hydroxy-eicosatetraenoic acid (12-HETE) [6, 7] and platelet activating factor (PAF) [8] . LTB 4 and 12-HETE are proinflammatory in human skin suggested by their ability to cause skin inflammation [9, 10] and epidermal proliferation [11] after topical application. 15-HETE is also a metabolite of AA formed by the 15-LO, but in contrast to LTB4 it has no proinflammatory effect in the skin. It inhibits both the formation [12] and the in vitro and in vivo effects of LTB 4 [13, 14] . Thus 15-HETE has antiinflammatory potential. In support of this is the observed improvement of psoriasis after intralesional injections of 15-HETE [15] and the improvement of carragheenan-induced experimental arthritis in dogs [16] . The regulation of eicosanoid release from human cells is poorly understood. It has been shown that the complement product C5a, FMLP and PAF have the capacity to stimulate the release of LTB 4 from neutrophils in vitro [17, 18] . It is unknown which factors are involved in the release of 15-HETE. However, it has been shown that substrate by itself initiates the production of 15-HETE and other 15-LO products [19, 20] . Also, it has been shown that 15-LO activity can be increased by certain non-steroidal antiinflammatory drugs/5-LO inhibitors [21, 22] and by certain hydroxy-eicosatetraenoic acids [23] . IL-8, formerly known as neutrophil-activating protein (NAP-I) [24, 25] is a newly discovered cytokine with the capacity to activate neutrophils [24, 26] and T lymphocytes in vitro as well as in vivo [24] . IL-8 can be produced by several different cell types present in the human skin including keratinocytes, fibroblasts [27] and endothelial cells [28] . Schr6der et al. [3] purified considerable quantities of IL-8 from extracts of psoriatic scales suggesting a pathophysiological role of this leukocyte activating cytokine in the development of psoriasis. It has recently been shown that IL-8 can stimulate the formation of LTB 4 and its omega-oxidation products by human neutrophils [25, 29] . The purpose of the present study was to determine whether IL-8 might affect not only the formation of LTB 4 but also the formation of 15-HETE.
Materials and methods

Cell preparation
Blood was obtained from healthy human volunteers, who had not taken non-steroidal antiinflammatory drugs during the preceding 2 weeks. Neutrophils were prepared as previously described [22] . After isolation the cells were suspended at a concentration of 12 x 106/ml in phosphate buffered saline (PBS, Sigma) without calcium and magnesium, pH 7.0. Cells were kept at 4~ until analysis.
Incubation procedure
820 ~tl neutrophils (12 x 106 cells/ml) were preincubated for 10 rain at 37~ with or without exogenous AA (99% pure, Sigma) at the concentrations mentioned. Then 100 Ixl of stock solutions (1 ng/ ml-1 mg/ml in PBS) of recombinant IL-8 (Dianippon Pharmac, Japan) were added together with 40 ~tl CaC12 (final concentration of 3.6 mM) and 40 rtl MgC1 z (final concentration of 1.9 raM). In incubations with ionophore A23187 (Sigma) A23187 was added as 100 gl of a stock solution (50 gM, 1% ethanol). Incubations were carried out for 5 rain. at 37~ in a shaking water bath. Control incubations without AA and without IL-8 or A23187 were carried out in the presence of ethanol. AA and A23187 were dissolved in ethanol and the final alcohol concentration never exceeded 0.2%. The incubations were terminated by cooling to 0 ~ in an ice water bath.
Extraction of lipids
After centrifugation (1,500 g for 10 min at 0~ the supernatant was collected and 2 ml of icecold methanol was added. This mixture was kept at -20~ for 15min and centrifuged (1,500 g for 10 min at 0 ~ to pellet cellular debris and denatured protein and the supematant was collected. Lipids were then extracted as previously described [22] . Briefly, the acidified supernatant (pH 3) was applied to ODS (octadecylsilyl) silica columns (C18-SEP-PAK, Waters, USA), and eluted sequentially with 2 ml water, 2 ml 25% methanol, 2 ml petroleum ether and 3 ml methanol. The methanol fraction was taken to dryness under a stream of N 2 and resuspended in 70% methanol.
Reversed-phase high performance liquid chromatography ( RP-HPLC)
Extracted lipids were separated by RP-HPLC as previously described. RP-HPLC was performed using a,system from Waters consisting of two M-6000A pumps, a Hypersil C18-column (5 gin, 100 x 4.6 mm I.D.), a model 490 programmable UV-detector, a model 730 data module and a model 721 system controller. The elution program was a modified isocratic method using methanol/water/acetic acid, 70:30:0.01 (v/v/v) as the mobile phase (solvent A). For the first 10 min the flow rate was 0.75 ml/min and thereafter the flow rate was increased to 1.25 ml/min. At 35 rain the mobile phase was changed to 100% methanol (solvent B) for 10 min to elute unreacted AA. Thereafter the All peaks in the chromatograms were identified and no unknown peaks were seen [22] . Recovery of 3H-labeled eicosanoids as internal standards was determined by scintillation counting in a Tricarb scintillation counter as previously described [22] . Tritiated standards were added before extraction and purification. The elution times were standardized daily. The eluent was collected by a fraction collector programmed to collect 1 rain fractions.
Statistical Analysis
Results are expressed as the mean_+ standard error of the mean (SEM). Statistical significance was assessed by Wilcoxon's ranksum test. A p value below 0.05 was considered significant.
Results
Fig . 1 shows the effect of IL-8 on the formation of 15-HETE, by human neutrophils in vitro in the presence of 10 I~M AA. IL-8 lead to a dose-dependent increase in 15-HETE formation in the concentration range 0.1-100ng/ml. At 100ng/ml there was a 40% increase in 15-HETE formation. For comparison also LTB 4 formation was determined and there was a 125% increase in LTB 4 at 100 ng/ml (data not shown). Incubations with 10 pM AA, but without IL-8 resulted in the formation of 4.7+0.9ng LTB4/107 cells and of 6.7+0.8 ng 15-HETE/107 cells. The increase in 15-HETE formation was dependent on the presence of exogenous AA (Fig. 2) Increased concentrations of AA lead to an increase in 15-HETE formation. IL-8 had an additive effect on AA-induced eicosanoid formation. Also the formation of LTB4 formation was dependent on the presence of exogenous AA (data not shown).
To assess the potency of IL-8 on eicosanoid formation, the effect of the calcium ionophore A23187, a potent activator of LTB 4 formation [30] was determined. 15-HETE release was increased 40% by IL-8 (100 ng/ml), whereas A23187 did not cause any significant increase in the formation of 15-HETE (Fig. 3) . In contrast, A23187 (5 gM) induced a 550% increase in LTB 4 formation, whereas the IL-8 induced LTB 4 release was increased by 125% at 100ng/ml (data not shown).
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Discussion
We have shown that IL-8 in a dose-dependent way increases the formation of LTB4 and 15-HETE by human neutrophils in vitro. This stimulation of both LTB4 and 15-HETE formation is dependent on the presence of exogenous arachidonic acid and therefore reflects increased activity of 5-LO and 15-LO. IL-8 was formerly known as neutrophil-activating protein (NAP-/), but we have recently suggested that this newly discovered cytokine should be termed interleukin-8 [24] . IL-8 has the capacity to stimulate a number of neutrophil functions [25, 26] . Furthermore, IL-8 is chemotactic for T lymphocytes [24] . It has recently been shown that IL-8 has the capacity to increase the formation of LTB4 from exogenous AA [25, 29] . In the present study we have confirmed this finding, and shown that in addition IL-8 also has the capacity to increase the formation of 15-HETE.
The requirement for exogenous AA for LTB4 formation depends on the stimulus. The calcium ionophore A23187 leads to the formation of large amounts of LTB 4 without the addition of AA by a mechanism that involves a rise in intracellular calcium and an activation of phospholipase [31] . As with IL-8, the formation of LTB 4 induced by FMLP or C5a requires the presence of exogenous AA [17] . These findings indicate that these agents stimulate LTB 4 formation without activating phospholipase A 2. Thus, substrate availability seems to be critical for the stimulation of LTB 4 formation by IL-8. Activation of 15-LO is poorly understood. There is evidence that the formation of 15-HETE only requires substrate for product formation [19, 20] and we have previously shown that increase in 15-HETE formation by neutrophils is associated with an inhibition of LTB 4 formation [22] . In this study we have found that AA leads to the formation of relatively large amounts of 15-HETE and that IL-8 is a potent stimulus for 15-HETE formation in contrast to A23187 that leads to no significant increase in 15-HETE formation (Fig. 3) . However, the activation of 15-LO still remains to be clarified. The present results indicate that the activity of IL-8 may partly be mediated through an activation of the 5-and 15-LO pathways of arachidonic acid (i.e. of LTB~ and 15-HETE formation). Because LTB 4 and 15-HETE have opposite effects on inflammatory processes (pro-inflammatory and anti-inflammatory, respectively), activation of their formation may be of importance in the regulation of inflammatory processes. Therefore, it remains to be determined whether IL-8 in vivo leads to an activation of LTB 4 and 15-HETE formation.
